Combined in vitro-in vivo approach to assess the hepatobiliary disposition of a novel oral thrombin inhibitor.
Matsson EM, Eriksson UG, Palm JE, Artursson P, Karlgren M, Lazorova L, Brännström M, Ekdahl A, Dunér K, Knutson L, Johansson S, Schützer KM, Lennernäs H.
Matsson EM, et al. Among authors: palm je.
Mol Pharm. 2013 Nov 4;10(11):4252-62. doi: 10.1021/mp400341t. Epub 2013 Oct 17.
Mol Pharm. 2013.
PMID: 24079718
Clinical Trial.